Twelve-month follow-up of Six Week Extended Dose Nevirapine randomized controlled trials: differential impact of extended-dose nevirapine on mother-to-child transmission and infant death by maternal CD4 cell count
Get This Resource
English: Web Page
Abstract with commentary from UCSF Global Health Sciences, Prevention and Public Health Group.
- Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials
||Lippincott Williams & Wilkins|